Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus
ACR Open Rheumatology · 2026-02 · 8 (2)
DOI: 10.1002/acr2.70165 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 30.01.2026. Verfasst von Raphael Teixeira Costa und 6 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital, Federal University of Alagoas, Maceió, Brazil. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Severalstudies have highlighted the role of Type I interferons (IFN‐I) in activating inflammatory pathways in lupus. However, no previous research focused on investigating the role of IFN‐I gene expression in the ophthalmologic involvement of systemic lupus erythematosus (SLE). We aimed to assess the association between the IFN‐I gene signature and ophthalmologic involvement in SLE.
Methods
Cross‐sectional study includes patients ≥18 years old, fulfilling the 2019 EULAR or American College of Rheumatology criteria for SLE. Ophthalmologic evaluation, the Systemic Lupus Erythematosus Disease Activity Index‐2K index, and blood sample collection were performed at the time of study assessment. Peripheral blood mononuclear cells were isolated, RNA was extracted, and complementary DNA was synthesized. Gene expression of IFI27, IFI44L, IFIT1, ISG15, RSAD2, and SIGLEC1 was assessed by real‐time polymerase chain reaction, using RPLP0 and EEF1A1 as reference genes for normalization. The median normalized relative quantity of the genes for each patient was used to calculate the fold change (FC) of the “Interferon Score.” Group comparisons were conducted using the Mann–Whitney U test, and correlations between variables were assessed using Spearman's rank correlation coefficient.
Results
We included 32 patients with SLE. Ocular involvement occurred in 62.5%, either due to aqueous‐deficient dry eye (46.88%) or lupus retinopathy. A higher expression of the IFN‐I gene was found in patients with ocular involvement (FC = 2.52 ± 1.96; P = 0.0027) compared with those without ophthalmologic changes.
Conclusion
The upregulation of the IFN‐I gene expression was associated with ophthalmologic involvement in SLE, potentially playing a role in its pathogenesis.
Autor:innen und Institutionen
- University Hospital, Federal University of Alagoas, Maceió, Brazil.
- Keizo Asami Institute, Federal University of Pernambuco, Recife, Brazil.
- Rheumathology Department, Coimbra University Hospital Centre, Coimbra, Portugal.
- Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
- Genetic Department, Federal University of Pernambuco, Recife, Brazil.
ORCID-Profile: Raphael Teixeira Costa
Zitieren
APA
Costa, R. T., Guaraná, W. L., da Silva Júnior, B. M., Clementino, J., Inês, L. S., Sandrin-Garcia, P., & Fragoso, T. S. (2026). Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus. ACR Open Rheumatology, 8(2). https://doi.org/10.1002/acr2.70165
Vancouver
Costa RT, Guaraná WL, da Silva Júnior BM, Clementino J, Inês LS, Sandrin-Garcia P, et al. Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus. ACR Open Rheumatology. 2026;8(2). doi:10.1002/acr2.70165
BibTeX
@article{Costa2026,
author = {Costa, Raphael Teixeira and Guaraná, Werbson Lima and da Silva Júnior, Braziliano Miguel and Clementino, Jaciel and Inês, Luís Sousa and Sandrin-Garcia, Paula and Fragoso, Thiago Sotero},
title = {Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus},
journal = {ACR Open Rheumatology},
year = {2026},
volume = {8},
number = {2},
doi = {10.1002/acr2.70165}
}
EUVIMED